Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid

Clinical Therapeutics

Volumn 29, Issue 2, 2007, Pages 359-370

  Penfold, Robert B ^a   Kelleher, Kelly J ^a  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

diffusion; geographic dissemination; geographic surveillance; heterogeneity; olanzapine; prescribing practices

Indexed keywords

OLANZAPINE;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MALE; MEDICAID; PRESCRIPTION; PSYCHOSIS; PUBLIC HEALTH; RURAL AREA; URBAN AREA;

ADOLESCENT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; INFORMATION DISSEMINATION; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MEDICAID; MICHIGAN; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; POPULATION SURVEILLANCE; PROBABILITY; RURAL HEALTH SERVICES; RURAL POPULATION; SEX FACTORS; URBAN HEALTH SERVICES; URBAN POPULATION;

EID: 34247526455     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.02.017     Document Type: Article

References (48)

1. Rushton J.L., Fant K.E., and Clark S.J. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics 114 (2004) e23-e28
2. Schneeweiss S., Glynn R.J., Avorn J., and Solomon D.H. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-timeprescriptions for COX-2 inhibitors. J Clin Epidemiol 58 (2005) 98-102
3. Spaulding R.J., Russo T., Cook D.J., and Doolittle G.C. Diffusion theory and telemedicine adoption by Kansas health-care providers: Critical factors in telemedicine adoption for improved patient access. J Telemed Telecare 11 Suppl 1 (2005) 107-109
4. Soumerai S.B., and Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 63 (1990) 549-556
5. Trepka M.J. Using surveillance data to develop and disseminate local childhood lead poisoning screening recommendations: Miami-Dade County's experience. Am J Public Health. 95 (2005) 56-558
6. Azocar F., Cuffel B., Goldman W., and McCarter L. The impact of evidence-based guideline dissemination for the assessment and treatment of major depression in a managed be haviowl health can organization. J Behav Health Serv Res. 30 (2003) 109-118
7. Myers B.A. Getting people to want sliced bread-an update on dissemination of the Guide to Community Preventative Services. J Pub Health Manag Pract 9 (2003) 545-551
8. Available at:. National Advisory Committee on Rural Health and Human Services. Health care quality: The rural context. Accessed August 29, 2005 (2003), US Dept of Health and Human Services. http://www.ruuralcommittee.hrsa.gov/QR03.htm
9. Hägerstrand T. Innovation Diffusion as a Spatial Process (1953), University of Chicago Press, Chicago Ill
10. Gould P.R. Spatial Diffusion (1969), Association of American Geographers, Washington DC
11. Brown L.A. Innovation Diffusion: A Naw Penpactive (1981), Methuen, London, UK
12. Rogers E.M. Diffusion of Innovations. 5th ed (2003), Free Press, New York, NY
13. Greenhalgh T., Robert G., MacFarlane F., et al. Diffusion of innovations im ser-vice organizations: Systematic review and recommendations. Milbank Q. 82 (2004) 581-629
14. Thomas C.P., Wallack S.S., Lee S., et al. Research into practice: Adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat. 24 (2003) 1-11
15. Knudsen H.K., Roman P.M., Ducharme L.J., and Johnson J.A. Organizational predictors of pharmacological innova tion adoption: The case of disulfiram. J Doug Issues 35 (2005) 559-574
16. Rappaport K.M., Forrest C.B., and Holtzman N.A. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res. 39 (2004) 927-947
17. Escarce J.J., Bloom B.S., Hillman A.L., et al. Diffusion of laparosozpic cholecysteuvmyamong general surgeons in the United States. Med Care 33 (1995) 256-271
18. Fuller B.E., Rieckmann T., McCarty C.J., et al. Adoption of naltrexone to treat alcohol dependence. J Subst Abuse Treat. 28 (2005) 273-280
19. Salmon J.W., Lin S.J., and Crawford S.Y. Influences on the adoption of new pharmaceutical technologies: The example of the fentanyl patch. Clin Res Regulatory Affairs 19 (2002) 397-412
20. Ciliska D., Robinson P., Armour T., et al. Diffusion and dissemination of evidence-based dietary strategies for the prevention of cancer. Nutr J. 4 (2005) 13
21. Phelps C.E. Diffusion of information in medical care. J Econ Perspect 23-42. (1992)
22. Fisher E.S., Wennberg J.E., Stukel T.A., and Sharp S.M. Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med. 331 (1994) 989-995
23. Available at:. US Food and Drug Administration. Center for Drug Evaluation and Research (CIDER). The National Drug code Directory [CIDER Web site]. Accessed (2006-February 14, 2007), CIDER, Washington, DC. http://www.fda.gov/cder/ndc
24. Michigan Medicaid Provider Enrollment File, 1998 & 2001 (2005), Health Management Associates, Lansing, Mich
25. Hudson C.G. Socioeconomic status and mental illness: Tests of the social causation and selection hy potheses. Am J Orthopsychiatry 75 (2005) 3-18
26. Sturm R., Ringel J.S., and Andreyeva T. Geographic disparities in children's mental health care. Pediatrics 112 (2003) e308
27. Bureau of Health Professions. Area Resource File (ARF) February 2003 Release. US Dept. of Health and Human Services (February 2003), Health Resources and Services Administration, Bureau of Health Professions, Rockville, Md
28. US Census Bureau. Census 2000 (2000-February 13, 2007). http://www.depts.wahsington.edu/uwruca/
29. Rural Health Research center. Rural-urban commuting codes. Available at: http://www.depts.wasington.edu/uwruca/. Accessed November 7, 2005
30. Rurall Health Research Center. The use of RUCAs in healthcare. Version 1.11. (2007-February 8, 2007). http://www.fammed.washinton.edu/wwamirhrc/rucas/use_healthcare.html
31. Clayton D., and Kaldor J. Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics 43 (1987) 671-681
32. Essock S.M., Covell N.H., Davis S.M., et al. Effectiveness of switching antipsychotic medications. Am J Psychiatry 163 (2006) 2090-2095
33. Phelps C.E. Information diffusion and best practice adoption. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of Health Economics Vol 1 (2000), Elsevier Science, Amsterdam, The Netherlands 223-264
34. Armstrong D., Reyburn H., and Jones R. A study of general practitioners, reasons for changing their prescribing behaviour. BMJ 312 (1996) 949-952
35. Gotham H.J. Diffusion of mental health and substance abuse treatments:Development, dissemination, and implementation. Clin Psycho Sci Pract. 11 (2004) 160-176
36. Jensen P.S. Ethical and pragmatic issues in the use of psychotropic agents in young children. Can J Psychiatry. 43 (1998) 585-588
37. West E., Baron D.N., Dowsett J., and Newton J.N. Hierarchies and cliques in the social networks of health care professionals: Implications for the design of dissemination strategies. Soc Sci Med 48 (1999) 633-646
38. Peay M., and Peay E.R. Patterns of prefer-ence for information sources in the adoption of new drugs by specialists. Soc Sci Med. 31 (1990) 467-476
39. (Suppl). Chen J.H., Schmit K., Chang H., et al. Use of Medicaid prescription data for syndromic surveillance-New York. MMWR Morb Mortal Wkly Rep. 54 (2005) 31-40
40. Burt R.S. Social contagion and innovation: Cohesion versus structural equivalence. Am J Sociol. 92 (1987) 1287-1335
41. Rizzo J.A. Physician uncertainty and the art of persuasion. Soc Sci Med. 37 (1993) 1451-1459
42. Bronnenberg B.J., and Mela C.F. Market roll-out and retailer adoption for new brands. Marketing Sci. 23 (2004) 500-518
43. Steffensen F.H., Sorensen H.T., and Olesen F. Diffusion of new drugs in Danish general practice. Fam Pract. 16 (1999) 407-413
44. Das D., Mostashari F., Weiss D., et al. Monitoring over-the-counter pharmacy sales for early outbreak detection-New York City, August 2001-Septembe, 2003. MMWR Mur Mortal Wkly Rep. 53 (2004) 235
45. Krishnamoorthy J., and King B.H. Openlabel olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 8 (1998) 107-113
46. Kumra S., Jacobsen L.K., Lenane M., et al. Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry 37 (1998) 377-385
47. Rogerson P.A. Monitoring point patterns for the development of space-time clusters. J Royal Stastical Soc A. 164 (2001) 87-96
48. Kulldorf M. Prospective time period-ic geographical disease surveillance using a scan statistic. J Royal Statistical Soc (Ser A) 164 (2001) 61-72